Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

2.

Managing employee apprehension toward handling cytotoxic drugs.

Moore TD, Hale KM, Cortese LM, Fillmore AD, Jozefczyk KG, Scala SM, Wellman GS.

Am J Hosp Pharm. 1985 Apr;42(4):826-31.

PMID:
4014233
3.

Developing guidelines for working with antineoplastic drugs.

Harrison BR.

Am J Hosp Pharm. 1981 Nov;38(11):1686-93.

PMID:
7304620
4.

Injectable-antineoplastic-drug practices in Michigan hospitals.

Cohen IA, Newland SJ, Kirking DM.

Am J Hosp Pharm. 1987 May;44(5):1096-105.

PMID:
3605120
5.

Safe handling practices of cytotoxic drugs: the results of a chapter survey.

Mahon SM, Casperson DS, Yackzan S, Goodner S, Hasse B, Hawkins J, Parham J, Rimkus C, Schlomer M, Witcher V.

Oncol Nurs Forum. 1994 Aug;21(7):1157-65.

PMID:
7971426
6.

Safe handling of cytotoxic drugs in the physician's office: a procedure manual model.

Carmignani SS, Raymond GG.

Oncol Nurs Forum. 1997 Jan-Feb;24(1 Suppl):41-8. Review.

PMID:
9010864
7.

Recommendations for handling cytotoxic drugs in hospitals.

Stolar MH, Power LA, Viele CS.

Am J Hosp Pharm. 1983 Jul;40(7):1163-71.

PMID:
6881154
8.

Precautions followed by personnel involved with the preparation of parenteral antineoplastic medications.

Tortorici MP.

Hosp Pharm. 1980 Jun;15(6):293, 295-6, 298-9 passim.

PMID:
10247268
9.

Monitoring occupational exposure to cancer chemotherapy drugs.

Baker ES, Connor TH.

Am J Health Syst Pharm. 1996 Nov 15;53(22):2713-23. Review.

PMID:
8931813
10.

Complying with workers' right-to-know legislation.

Knoeck MJ Jr, Wadd WB, Giese RM.

Am J Hosp Pharm. 1985 Sep;42(9):1974-6.

PMID:
4050815
11.

Recommendations for the safe handling of injectable antineoplastic drug products.

Zimmerman PF, Larsen RK, Barkley EW, Gallelli JF.

Am J Hosp Pharm. 1981 Nov;38(11):1693-5.

PMID:
7304621
12.

[Guidelines for the health protection and safety of workers exposed to antineoplastic drugs].

Palazzo S, Bernardo G, Draicchio F, Lucchini R, Merlano M, Minguzzi M, Molinaro V, Scanni A, Sossai D, Villa L.

Med Lav. 1996 May-Jun;87(3):255-64. Italian.

PMID:
8965737
13.

The handling of antineoplastic drugs in a major cancer center.

Hoffman DM.

Hosp Pharm. 1980 Jun;15(6):302-4.

PMID:
10247269
14.

Quality assurance: ensuring pharmacy personnel follow procedures for handling cytotoxic drugs.

Scott BE, White SJ, Matthews T.

Hosp Pharm. 1987 Jan;22(1):45-9.

PMID:
10280293
15.

Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide.

Sugiura S, Asano M, Kinoshita K, Tanimura M, Nabeshima T.

J Oncol Pharm Pract. 2011 Mar;17(1):14-9. doi: 10.1177/1078155209358632. Epub 2010 Feb 23.

PMID:
20179165
16.

Legal issues associated with the handling of cytotoxic drugs.

Provost GJ.

Am J Hosp Pharm. 1984 Jun;41(6):1115-21.

PMID:
6234797
17.

Exposure of hospital pharmacists and nurses to antineoplastic agents.

McDevitt JJ, Lees PS, McDiarmid MA.

J Occup Med. 1993 Jan;35(1):57-60.

PMID:
8423505
18.
19.

Controlling occupational exposure to hazardous drugs. Occupational Safety and Health Administration.

[No authors listed]

Am J Health Syst Pharm. 1996 Jul 15;53(14):1669-85.

PMID:
8827233
20.

Occupational exposure to tuberculosis--OSHA. Proposed rule and notice of public hearing.

[No authors listed]

Fed Regist. 1997 Oct 17;62(201):54160-308.

PMID:
10177300

Supplemental Content

Support Center